KO Stock Analysis: The Coca-Cola | NYSE
Beverages - Non-Alcoholic | NYSE, USA | Market Cap: 419.177m USD | 12M Return: 41.4% | US1912161007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.73B
EPS Trend: 97.6%
Qual. Beats: 6
Rev. Trend: 94.0%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
The Coca-Cola Company is a global nonalcoholic beverage manufacturer founded in 1886 and headquartered in Atlanta, Georgia. It produces and sells sparkling soft drinks, water, sports drinks, coffee, tea, juices, value-added dairy, and plant-based beverages under a broad portfolio of brands, including Coca-Cola, Diet Coke, Sprite, Fanta, Dasani, Smartwater, Powerade, Costa, and fairlife. The company also sells beverage concentrates, syrups, and fountain syrups to restaurant and convenience store retailers.
The company operates a concentrate-based business model, generating revenue primarily by selling syrups and concentrates to a global network of independent bottling partners, who handle manufacturing, packaging, and distribution alongside wholesalers and retailers. This asset-light structure, common in the Consumer Staples sector, allows Coca-Cola to focus on brand marketing and concentrate production while bottlers manage capital-intensive operations. Its shares trade on the NYSE under the ticker KO, and the company has been publicly listed since 1919.
- Fairlife and BodyArmor premium portfolio lifts operating margins
- Strong dollar pressures international revenue translation
- North America sparkling volumes soften on health-conscious shift
| Net Income: 14.6b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 7.98 > 1.0 |
| NWC/Revenue: 17.86% < 20% (prev 9.96%; Δ 7.90% < -1%) |
| CFO/TA 0.15 > 3% & CFO 16.2b > Net Income 14.6b |
| Net Debt (26.4b) to EBITDA (20.4b): 1.29 < 3 |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.31b) vs 12m ago 0.0% < -2% |
| Gross Margin: 62.32% > 18% (prev 61.63%; Δ 0.69% > 0.5%) |
| Asset Turnover: 47.72% > 50% (prev 44.95%; Δ 2.77% > 0%) |
| Interest Coverage Ratio: 12.69 > 6 (EBIT TTM 19.4b / Interest Expense TTM 1.53b) |
| A: 0.08 (Total Current Assets 33.3b - Total Current Liabilities 24.2b) / Total Assets 108b |
| B: 0.80 (Retained Earnings 85.9b / Total Assets 108b) |
| C: 0.18 (EBIT TTM 19.4b / Avg Total Assets 107b) |
| D: 0.55 (Book Value of Equity 37.4b / Total Liabilities 68.4b) |
| Altman-Z'' = 4.94 = AAA |
| DSRI: 0.84 (Receivables 3.57b/3.95b, Revenue 51.1b/47.7b) |
| GMI: 0.99 (GM 61.63% / 62.32%) |
| AQI: 0.94 (AQ_t 0.60 / AQ_t-1 0.64) |
| SGI: 1.07 (Revenue 51.1b / 47.7b) |
| TATA: -0.01 (NI 14.6b - CFO 16.2b) / TA 108b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of November 19, 2026, the stock is trading at USD 98.09 with a total of 16,529,975 shares traded. Over the past week, the price has changed by +0.53%, over one month by +5.00%, over three months by +11.10% and over the past year by +41.39%.
Current recommended Stop Loss: 95.00 (which is 3.2% or 1.9 ATR below the current price).
The Coca-Cola has received a consensus analysts rating of 4.28. Therefore, it is recommended to buy KO.
- StrongBuy: 13
- Buy: 7
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 98.4 | 0.3% |
P/E Trailing = 28.7434
P/E Forward = 27.933
P/S = 8.2105
P/B = 11.2313
P/EG = 4.1113
Revenue TTM = 51.1b USD
EBIT TTM = 19.4b USD
EBITDA TTM = 20.4b USD
Long Term Debt = 36.6b USD (from longTermDebt, last quarter)
Short Term Debt = 5.00b USD (from shortTermDebt, last quarter)
Debt = 42.9b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 26.4b USD (calculated: Debt 42.9b - CCE 16.6b)
Enterprise Value = 446b USD (419b + Debt 42.9b - CCE 16.6b)
Interest Coverage Ratio = 12.69 (Ebit TTM 19.4b / Interest Expense TTM 1.53b)
EV/FCF = 31.20x (Enterprise Value 446b / FCF TTM 14.3b)
FCF Yield = 3.21% (FCF TTM 14.3b / Enterprise Value 446b)
FCF Margin = 27.97% (FCF TTM 14.3b / Revenue TTM 51.1b)
Net Margin = 28.65% (Net Income TTM 14.6b / Revenue TTM 51.1b)
Gross Margin = 62.32% ((Revenue TTM 51.1b - Cost of Revenue TTM 19.2b) / Revenue TTM)
Gross Margin QoQ = 63.15% (prev 62.89%)
Tobins Q-Ratio = 4.13 (Enterprise Value 446b / Total Assets 108b)
Interest Expense / Debt = 3.56% (Interest Expense 1.53b / Debt 42.9b)
Taxrate = 17.36% (3.10b / 17.9b)
NOPAT = 16.0b (EBIT 19.4b * (1 - 17.36%))
Current Ratio = 1.38 (Total Current Assets 33.3b / Total Current Liabilities 24.2b)
Debt / Equity = 1.15 (Debt 42.9b / totalStockholderEquity, last quarter 37.4b)
Debt / EBITDA = 1.29 (Net Debt 26.4b / EBITDA 20.4b)
Debt / FCF = 1.85 (Net Debt 26.4b / FCF TTM 14.3b)
Total Stockholder Equity = 34.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.67% (Net Income 14.6b / Total Assets 108b)
RoE = 42.00% (Net Income TTM 14.6b / Total Stockholder Equity 34.8b)
RoCE = 27.16% (EBIT 19.4b / Capital Employed (Equity 34.8b + L.T.Debt 36.6b))
RoIC = 18.61% (NOPAT 16.0b / Invested Capital 86.2b)
WACC = 4.28% (E(419b)/V(462b) * Re(4.42%) + D(42.9b)/V(462b) * Rd(3.56%) * (1-Tc(0.17)))
Discount Rate = 4.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -74.08 | Cagr: -0.05%
[DCF] Terminal Value 77.97% ; FCFF base≈10.8b ; Y1≈12.4b ; Y5≈18.2b
[DCF] Fair Price = 57.59 (EV 274b - Net Debt 26.4b = Equity 248b / Shares 4.30b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 97.63 | EPS CAGR: 7.31% | SUE: 2.74 | # QB: 6
Revenue Correlation: 94.00 | Revenue CAGR: 3.68% | SUE: 1.31 | # QB: 1
EPS current Quarter (2027-03-31): EPS=0.89 | Chg30d=-0.54% | Revisions=-31% | Analysts=13
EPS current Year (2026-12-31): EPS=3.34 | Chg30d=+1.14% | Revisions=+88% | GrowthEPS=+11.3% | GrowthRev=+5.0%
EPS next Year (2027-12-31): EPS=3.53 | Chg30d=+0.12% | Revisions=-8% | GrowthEPS=+5.7% | GrowthRev=-3.1%
[Analyst] Revisions Ratio: +29% (up=36, down=19)